Special Edition: Obesity—The Changing Landscape
From DOC Updates by American Diabetes Association
May 26, 2026 · 34 min
About this episode
The episode discusses the evolving science and cardiometabolic diseases associated with obesity.
In the first episode of this series on Obesity, our host is joined by Dr. Mikhail Kosiborod to discuss the evolving science and cardiometabolic diseases associated with obesity. This special episode is sponsored with support from AstraZeneca . Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Mikhail Kosiborod , MD, Senior Vice President Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D at AstraZeneca. Selected references: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association . Circulation October 2023
People in this episode
Host: Neil Skolnik
Guest: Mikhail Kosiborod
Topics covered
- Obesity
- Cardiometabolic diseases
- Evolving science
- Health
- Medicine
Keywords
- obesity
- cardiometabolic diseases
- AstraZeneca
- health
- medicine
- Neil Skolnik
- Mikhail Kosiborod
- American Diabetes Association
Sponsors
AstraZeneca
Mentioned in this episode
Organizations: American Diabetes Association, American Heart Association
Books & works: Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association
More episodes of DOC Updates
- Special Edition: Hypertension Part 2—Advanced Hypertension Management: Uncontrolled and Resistant Hypertension and the Importance of Aldosterone · September 8, 2026 · 40 min
- Special Edition: Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH) · September 3, 2026 · 23 min
- Special Edition: Evidence-Based Strategies for Weight Loss and Long-Term Weight Maintenance · August 24, 2026 · 32 min
- Special Edition: What's Next—The Role of Health Systems in Managing CKD Associated with T1D & T2D · August 17, 2026 · 33 min
- Katherine Tuttle on SGLT2s & CKD in T2D, Alexander Turchin on medications after Metformin, and High vs. Low CVD Risk, the ADA's statement on employment and diabetes, and more! · August 10, 2026 · 36 min
- Impact of Finerenone on Albuminuria in T1D, National Trends in Out-of-Pocket Cost for Glucose-Lowering Drugs, and more! · August 10, 2026 · 32 min
Explore listener stats, chart rankings, contacts and more on the DOC Updates podcast page.